Investigating the best treatment for infants with opioid withdrawal syndrome
Neonatal Treatment Trial
This study is looking at the best medications to help newborns who are going through withdrawal from opioids, and by joining in, families can help improve care for these little ones.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10916554 on NIH RePORTER |
What this research studies
This research focuses on Neonatal Opioid Withdrawal Syndrome (NOWS), a condition affecting infants exposed to opioids. The study will compare the effectiveness of three commonly used medications to determine the best pharmacological treatment for these infants. By participating in this trial, families can contribute to understanding how to improve care for newborns experiencing withdrawal symptoms. The research will take place across multiple centers, ensuring a diverse patient population and robust data collection.
Who could benefit from this research
Good fit: Ideal candidates for participation are infants aged 0-4 weeks who are diagnosed with Neonatal Opioid Withdrawal Syndrome.
Not a fit: Patients who are not diagnosed with NOWS or are older than 4 weeks may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols for infants suffering from opioid withdrawal, enhancing their health outcomes.
How similar studies have performed: Previous research has indicated variability in treatment outcomes for NOWS, suggesting that this comparative effectiveness approach could yield significant insights.
Where this research is happening
Philadelphia, United States
- Children's Hosp of Philadelphia — Philadelphia, United States (Active)
Researchers
- Principal investigator: Lorch, Scott a — Children's Hosp of Philadelphia
- Study coordinator: Lorch, Scott a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.